| Literature DB >> 35096788 |
Giannina Espina1, Sebastián A Muñoz-Ibacache1, Paulina Cáceres-Moreno1, Maximiliano J Amenabar1, Jenny M Blamey1,2.
Abstract
With the advent of the industrial revolution, the use of toxic compounds has grown exponentially, leading to a considerable pollution of the environment. Consequently, the development of more environmentally conscious technologies is an urgent need. Industrial biocatalysis appears as one potential solution, where a higher demand for more robust enzymes aims to replace toxic chemical catalysts. To date, most of the commercially available enzymes are of mesophilic origin, displaying optimal activity in narrow ranges of temperature and pH (i.e., between 20°C and 45°C, neutral pH), limiting their actual application under industrial reaction settings, where they usually underperform, requiring larger quantities to compensate loss of activity. In order to obtain novel biocatalysts better suited for industrial conditions, an efficient solution is to take advantage of nature by searching and discovering enzymes from extremophiles. These microorganisms and their macromolecules have already adapted to thrive in environments that present extreme physicochemical conditions. Hence, extremophilic enzymes stand out for showing higher activity, stability, and robustness than their mesophilic counterparts, being able to carry out reactions at nonstandard conditions. In this brief research report we describe three examples to illustrate a stepwise strategy for the development and production of commercial extremozymes, including a catalase from an Antarctic psychrotolerant microorganism, a laccase from a thermoalkaliphilic bacterium isolated from a hot spring and an amine-transaminase from a thermophilic bacterium isolated from a geothermal site in Antarctica. We will also explore some of their interesting biotechnological applications and comparisons with commercial enzymes.Entities:
Keywords: Antarctica; amine-transaminase; biocatalysts; catalase; extremophiles; laccase
Year: 2022 PMID: 35096788 PMCID: PMC8790482 DOI: 10.3389/fbioe.2021.752281
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Strategy for the screening and production of new extreme biocatalysts from environmental samples. Culture dependent and independent approaches to discover novel extremozymes are depicted in the discovery phase.
Quality control points (QCP) defined for enzyme production.
| Quality control points | Step | Control point |
|---|---|---|
| QCP1 | Seed culture preparation | Control of biomass growth from lab-scale bioreactor (wet biomass yield, g/L) |
| QCP2 | Biomass production | Control of biomass growth from a larger bioreactor (wet biomass yield, g/L) |
| QCP3 | Protein extract | Control of enzyme activity (U/ml) and protein concentration (mg/ml) of the extract prior purification |
| QCP4 | Protein purification | Control of specific activity (U/mg) of the purified protein |
| QCP5 | Final product processing | Control of specific activity (U/mg) and protein concentration (mg/ml) of the final product |
Comparison of native and recombinant enzyme production.
|
|
|
| |
|---|---|---|---|
|
| |||
| Native biomass (5L Biostat-B Bioreactor) | 5 g/L | 10 g/L spore, 16 g/L biomass | 8 g/L |
| Recombinant biomass (5L Biostat-B Bioreactor) | 5 g/L | 20 g/L | 30 g/L |
| Optimized recombinant biomass (5L Biostat-B Bioreactor) | 16 g/L | 25 g/L | Ongoing experiments |
| Scaled-up recombinant biomass (40L Biostat-C Bioreactor) | 25 g/L | 25 g/L | Ongoing experiments |
|
| |||
| Native enzymatic yield (5L Biostat-B Bioreactor) | 8.5 mg protein/L culture | 4.4 mg protein/L culture | 12 mg protein/L culture |
| Recombinant enzymatic yield (5L Biostat-B Bioreactor) | 100 mg protein/L culture | 200 mg protein/L culture | 28 mg protein/L culture |
| Optimized recombinant enzymatic Yield (5L Biostat-B Bioreactor) | 550 mg protein L culture | 500 mg protein/L culture | Ongoing experiments |
| Scaled-up recombinant enzymatic Yield (40L Biostat-C Bioreactor) | 443.7 mg protein/L culture | 450 mg protein/L culture | Ongoing experiments |
|
| |||
| Native specific activity (5L Biostat-B Bioreactor) | 1301 U/mg | 1000 U/mg | 0.52 U/mg |
| Recombinant specific activity (5L Biostat-B Bioreactor) | 4000 U/mg | 200000 U/mg | 6 U/mg |
| Optimized specific activity (5L Biostat-B Bioreactor) | 10000 U/mg | 400000 U/mg | Ongoing experiments |
| Scaled-up specific activity (40L Biostat-C Bioreactor) | ≥8600 U/mg | ≥300000 U/mg | Ongoing experiments |
FIGURE 2Comparison of commercial catalases (A) and laccases (B) at different temperatures. Each commercial enzyme was assayed at their optimum pH, as reported by each manufacturer in their data sheets. The enzyme assays used were described in the method section for each enzyme. One unit (U) of CAT activity was defined as the decomposition of 1 µmol of H2O2 per minute. One unit (U) of laccase activity was defined as a change in absorbance at 530 nm of 0.001 per minute, under the assay conditions. Error bars indicate standard deviation of triplicate measurements.